Existing Cancer Therapy in Narrow Use Shows Significant Activity Against Other Cancers

A drug currently used in just 1% of cancers has significant potential against the remaining 99%, according to a new study from UH Seidman Cancer Center and Case

Related Keywords

Case Western Reserve University ,Ohio ,United States ,United Kingdom ,Jordan ,Cleveland ,Scotland ,America ,Atlantic Ocean ,David Bajor ,Ali Vaziri Gohar ,Jennifer Morton ,Uh Cleveland Medical Center ,University Hospitals ,Linkedin ,Twitter ,Technion Israel Institute Of Technology ,University Hospitals Cleveland Medical Center ,Facebook ,Oxford University ,Uh Seidman Cancer Center ,Case Comprehensive Cancer Center ,University Hospitals Cleveland ,Case Western Reserve University School Of Medicine ,Gateway For Cancer Research ,Ohio Medical University ,Pancreatic Cancer Research ,Beatson Institute ,Research Institutes ,Jordan Winter ,Division Chief ,Surgical Oncology ,Seidman Cancer Center ,Peggy Garson Family Endowed Chair ,Joy Weinberger Family Master Clinician ,Postdoctoral Fellow ,Case Western Reserve University School ,Cancer Research ,Peggy Garson ,Case Western Reserve School ,Developmental Therapeutics Program ,Northeast Ohio Medical University ,Technion Israel Institute ,Donald Women ,Cancer Center ,Case Comprehensive Cancer ,Medical Center ,Care Delivery ,Northeast Ohio ,Newswise ,Ancer Research Pancreatic Cancer Therapy ,Healthcare ,Tory Ideas Medicine ,Ature Journal ,All Journal News ,